Suppr超能文献

哮喘患者气道中表面活性蛋白D的表达及气道上皮细胞人源模型中白细胞介素-13对表面活性蛋白D的调节作用

Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium.

作者信息

Xu Jie, Singhera Gurpreet K, Dorscheid Delbert R

出版信息

Respir Res. 2015 Feb 15;16(1):26. doi: 10.1186/s12931-015-0177-7.

Abstract

BACKGROUND

Surfactant protein D (SP-D), a pattern recognition molecule, has been shown to play roles in host defense such as opsonisation, aggregation of pathogens, and modulation of the inflammatory response. In light of infection-induced exacerbations and damage to the airway epithelium from inflammation, these functions of SP-D make it relevant in the development and pathogenesis of asthma.

METHODS

Expression of SP-D was examined in human airway sections and primary airway epithelial cells (AEC) grown in air-liquid interface (ALI) cultures and comparisons were made between those from asthmatic and non-asthmatic donors. ALI cultures of AEC from non-asthmatic donors were examined for SP-D, Mucin 5AC, and cytokeratin-5 expression at different stages of differentiation. Interleukin-13 (IL-13) treatment of airway epithelium and its effect on SP-D expression was studied using ALI and monolayer cultures of primary AEC from non-asthmatic and asthmatic donors.

RESULTS

Airway epithelium of asthmatics, compared to that of non-asthmatics, expressed increased levels of SP-D as demonstrated in airway tissue sections (fraction of epithelium 0.66 ± 0.026 vs. 0.50 ± 0.043, p = 0.004) and ALI cultures (fraction of epithelium 0.50 ± 0.08 vs. 0.25 ± 0.07). SP-D expression decreased as ALI cultures differentiated from 7 days to 21 days (fraction of epithelium 0.62 ± 0.04 to 0.23 ± 0.03, p = 0.004). Treatment with IL-13 decreased SP-D expression in both ALI cultures (fraction of epithelium 0.21 ± 0.06 vs. 0.62 ± 0.04, p = 0.0005) and monolayer cultures (protein expression fold change 0.62 ± 0.05) of non-asthmatic AEC; however, IL-13 had no significant effect on SP-D expression in monolayer cultures of asthmatic AEC. Experiments with non-asthmatic monolayer cultures indicate IL-13 exert its effect on SP-D through the IL-13 receptor alpha1 and transcription factor STAT6.

CONCLUSIONS

SP-D is expressed differently in airways of asthmatics relative to that of non-asthmatics. This can have implications on the increased susceptibility to infections and altered inflammatory response in asthmatic patients. Future functional studies on the role of SP-D in asthma can provide better insight into defects in the structure and regulation of SP-D.

摘要

背景

表面活性蛋白D(SP-D)是一种模式识别分子,已被证明在宿主防御中发挥作用,如调理作用、病原体聚集以及炎症反应的调节。鉴于感染引起的病情加重以及炎症对气道上皮的损伤,SP-D的这些功能使其与哮喘的发生发展及发病机制相关。

方法

检测人气道切片以及气液界面(ALI)培养的原代气道上皮细胞(AEC)中SP-D的表达,并对哮喘患者和非哮喘患者供体的样本进行比较。检测非哮喘患者供体的AEC在ALI培养不同分化阶段的SP-D、黏蛋白5AC和细胞角蛋白-5的表达。使用非哮喘患者和哮喘患者供体的原代AEC的ALI培养和单层培养,研究白细胞介素-13(IL-13)对气道上皮的作用及其对SP-D表达的影响。

结果

与非哮喘患者相比,哮喘患者气道上皮中SP-D的表达水平升高,这在气道组织切片(上皮细胞比例0.66±0.026对0.50±0.043,p = 0.004)和气液界面培养(上皮细胞比例0.50±0.08对0.25±0.07)中均得到证实。随着ALI培养从7天分化到21天,SP-D表达下降(上皮细胞比例从0.6 ± 0.04降至0.23 ± 0.03,p = 0.004)。IL-13处理降低了非哮喘患者AEC的ALI培养(上皮细胞比例0.21±0.06对0.62±0.04,p = 0.0005)和单层培养(蛋白表达倍数变化0.62±0.05)中SP-D的表达;然而,IL-13对哮喘患者AEC单层培养中SP-D的表达没有显著影响。非哮喘患者单层培养的实验表明,IL-13通过IL-13受体α1和转录因子STAT6对SP-D发挥作用。

结论

与非哮喘患者相比,哮喘患者气道中SP-D的表达存在差异。这可能对哮喘患者感染易感性增加和炎症反应改变产生影响。未来关于SP-D在哮喘中作用的功能研究可以更好地洞察SP-D结构和调节方面的缺陷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验